四環醫藥(00460.HK)附屬收購美國美容設備開發商Genesis
四環醫藥(00460.HK)公佈,其附屬耀忠國際收購美國Genesis Biosystems的全部股權。Genesis爲一家高品質美學和生物醫學產品製造商,主要從事美容設備的開發、製造和分銷,專注於微通道系統和脂肪採集產品,用於美容護膚治療以及整形手術。
Genesis的微通道系統產品包括Derma Genesis、Dermacel和DermaFrac等系列產品。其脂肪採集系統LipiVage是一種創新產品,集團美國附屬Meiyen Laboratory於今年6月已就該產品與Genesis達成戰略合作,取得該產品在大中華區及南韓的獨家代理權。
公司認爲,是次收購將進一步擴充集團的醫美產品管線,夯實集團在非手術和手術類醫美領域的全面佈局,及進一步加快推動集團醫美業務從產品代理向一體化平臺型企業發展的進程。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.